Cases of aquaporin-4-positive neuromyelitis optica spectrum disorder with successful tapering of prednisolone to less than 3 mg/day after satralizumab administration

Neurol Sci. 2023 Aug;44(8):2967-2970. doi: 10.1007/s10072-023-06754-4. Epub 2023 Mar 18.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Aquaporin 4
  • Autoantibodies
  • Humans
  • Neuromyelitis Optica* / diagnostic imaging
  • Neuromyelitis Optica* / drug therapy
  • Prednisolone / therapeutic use

Substances

  • satralizumab
  • Prednisolone
  • Aquaporin 4
  • Antibodies, Monoclonal, Humanized
  • Autoantibodies